Masimo Corp (NASDAQ:MASI)
CAPS Rating:
A global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care.
A global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care.
Recs
This is an interesting small cap involved in non-invasive monitoring - several "name" hospitals are early adopters ... but at $24.25 with a $1.1b market cap, current stock price appears rich, both on a fundamental and technical basis in the intermediate term (IPO was around $17). Seller here, looking for buying oppt. back in the teens.